topotecan has been researched along with leupeptins in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christmann, M; Kaina, B; Tomicic, MT | 1 |
1 other study(ies) available for topotecan and leupeptins
Article | Year |
---|---|
Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.
Topics: Animals; Antineoplastic Agents; Apoptosis; cdc25 Phosphatases; Cell Cycle; Checkpoint Kinase 1; DNA Damage; DNA Topoisomerases, Type I; DNA, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Humans; Leupeptins; Mice; Mutation; Protein Kinases; Topoisomerase I Inhibitors; Topotecan; Tumor Suppressor Protein p53 | 2005 |